CrushSCI.com
90.4Average days
86Median days
48Fastest days
148Longest days
1122025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

108 days

Tramadol potentiates chemotherapy efficacy in hepatocellular carcinoma cells

Authors
Hsiu-Lung Fan; Shu-Ting Liu; Zih-Syuan Wu; Yi-Hsuan Huang; Shih-Ming Huang; Teng-Wei Chen; Zhi-Fu WuShow moreShow less
Affiliations
1. Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Tri-Service General Hospital, National Defense Medical University; 2. Graduate Institute of Biochemistry, College of Biomedical Sciences, National Defense Medical University; 3. Department of Anesthesiology, School of Medicine, College of Medicine, Tri-Service General Hospital, National Defense Medical University; 4. Department of Anesthesiology, E-Da Hospital, I-Shou University; 5. Department of Anesthesiology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University; 6. Center for Regional Anesthesia and Pain Medicine, Wan Fang Hospital, Taipei Medical UniversityShow moreShow less
Source PDF DOI Publisher page
88 days

Recent advances in the development of tag-targeted protein degradation systems

Authors
Bizhi Li; Yang Lu; Jinxin Che; Xiaowu DongShow moreShow less
Affiliations
1. Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University; 2. Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City UniversityShow moreShow less
Source PDF DOI Publisher page
148 days

Anticandidal activity of L-β-(isoxazolin-5-on-2-yl)-alanine due to the inhibition of O -acetyl-L-homoserine sulfhydrylase and cystathionine γ-synthase

Authors
Aleksandra Kuplińska; Edyta Składanek; Hira Zahoor Rajput; Joanna Stefaniak-Skorupa; Kamila Rząd; Katarzyna Kozłowska-Tylingo; Marek Wojciechowski; Milewska Maria J; Iwona Gabriel; Sławomir MilewskiShow moreShow less
Affiliations
1. Department of Pharmaceutical Technology and Biochemistry, Gdańsk University of Technology; 2. Department of Organic Chemistry, Gdańsk University of TechnologyShow moreShow less
Source PDF DOI Publisher page
53 days

Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer cells

Authors
Yi-Wen Wu; Chun-Lin Yang; Yu-Ting Fang-Chin; Yun-Hsuan Yeh; Bor-Jiun Chen; Tzu-Ying Sung; Jung-Chun Chu; Tony Eight Lin; Shih-Chung Yen; Jui-Hua Hsieh; Sing-Han Huang; Cheng-Ying Chu; Kai-Chien Yang; Kai-Cheng Hsu; Shiow-Lin PanShow moreShow less
Affiliations
1. Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University; 2. Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University; 3. Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong (Shenzhen); 4. Division of Translational Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health; 5. Department of Digital Biology, Graphen Drugomics Inc.; 6. CRISPR Gene Targeting Core, Taipei Medical University; 7. TMU Research Center of Cancer Translational Medicine, Taipei Medical University; 8. Department and Graduate Institute of Pharmacology, National Taiwan University College of Medicine; 9. Ph.D. Program in Innovative Medical Technology Research and Development Industry, College of Medical Science and Technology, Taipei Medical University; 10. Cancer Center, Wan Fang Hospital, Taipei Medical UniversityShow moreShow less
Source PDF DOI Publisher page
145 days

Structure-activity relationship of Cu(II) and Pd(II) thiosemicarbazone complexes with anticancer and antibacterial properties

Authors
Bartłomiej Rogalewicz; Magdalena Iwan; Marcin Świątkowski; Mariola Michalczuk; Joanna Kubik; Ewelina Humeniuk; Agnieszka Korga-Plewko; Monika Pitucha; Tomasz Boruta; Tomasz Sierański; Jakub Kubicki; Sylwia Ścieszka; Edyta Kordialik-Bogacka; Agnieszka CzylkowskaShow moreShow less
Affiliations
1. Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology; 2. Department of Toxicology, Medical University of Lublin; 3. Independent Medical Biology Unit, Medical University of Lublin; 4. Independent Radiopharmacy Unit, Faculty of Pharmacy, Medical University of Lublin; 5. Faculty of Process and Environmental Engineering, Department of Bioprocess Engineering, Lodz University of Technology; 6. Institute of Fermentation Technology and Microbiology, Faculty of Biotechnology and Food Sciences, Lodz University of TechnologyShow moreShow less
Source PDF DOI Publisher page
146 days

Rational structure-guided identification of a Bcl-2-targeting peptide with antiproliferative effects on colorectal cancer cells

Authors
Xing Jin; Shudan Yang; Qianqian Wang; Shutong Chen; Yi-Nan Wang; Yang YangShow moreShow less
Affiliations
1. Department of Laboratory Medicine, The Affiliated Hospital of Yangzhou University, Yangzhou University; 2. Department of Pharmaceutical Analysis, China Pharmaceutical UniversityShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY take to review a manuscript?

As of 2026-11-19, CrushSCI has 18 complete review records for JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. The fastest paper went from submission to acceptance in 48 days (Recent progress in small molecules targeting the acidic tumor microenvironment, received 2026-05-27, accepted 2026-07-14); the slowest took 148 days. The average is 90.4 days and the median is 86 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.